TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Sana Pharma Sverige AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
7,706
|
6,396
|
6,931 |
| Financial expenses |
14
|
10
|
1 |
| Earnings before taxes |
-1,371
|
147
|
-3 |
| EBITDA |
-1,330
|
179
|
25 |
| Total assets |
16,351
|
9,985
|
3,550 |
| Current assets |
16,303
|
9,972
|
3,516 |
| Current liabilities |
15,323
|
9,586
|
3,299 |
| Equity capital |
1,028
|
399
|
251 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
5
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
6.3%
|
4.0%
|
7.1% |
| Turnover per employee |
1,541
|
1,599
|
1,733 |
| Profit as a percentage of turnover |
-17.8%
|
2.3%
|
0.0% |
| Return on assets (ROA) |
-8.3%
|
1.6%
|
-0.1% |
| Current ratio |
106.4%
|
104.0%
|
106.6% |
| Return on equity (ROE) |
-133.4%
|
36.8%
|
-1.2% |
| Change turnover |
1,310
|
-535
|
4,039 |
| Change turnover % |
20%
|
-8%
|
140% |
| Chg. No. of employees |
1
|
0
|
1 |
| Chg. No. of employees % |
25%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.